Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for digital ulcers in systemic sclerosis (RAPIDS-2)
NCT00077584Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Oct 2003
- Primary completion
- Mar 2005
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
A Phase 3 trial of bosentan in systemic sclerosis (SSc), digital ulcer (DU), sponsored by Actelion Pharmaceuticals Ltd. Started Oct 2003; status: completed.
02
Drugs
bosentan
03
Conditions
systemic sclerosis (SSc)digital ulcer (DU)
Beyond the preview
Go deeper on NCT00077584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077584.